NEDD4L and neoplasm: Additionally, Wang et al. [34] showed that NEDD4 (a homolog of NEDD4L) drives tumor growth in IGF1 signal pathway-dependent GC by modulating the PTEN-IRS1 axis, with clinical data indicating that high NEDD4 and IGF1 co-expression predicts poor prognosis.